Literature DB >> 4797185

Intrasubject variation in elimination half-lives of drugs which are appreciably metabolized.

J G Wagner.   

Abstract

Mesh：

Substances：

Year:  1973        PMID： 4797185     DOI： 10.1007/bf01059628

Source DB:  PubMed          Journal:  J Pharmacokinet Biopharm        ISSN： 0090-466X


× No keyword cloud information.
  9 in total

1.  Local and systemic tolerance, absorption and excretion of clindamycin hydrochloride after intramuscular administration.

Authors:  E Novak; J G Wagner; D J Lamb
Journal:  Int Z Klin Pharmakol Ther Toxikol       Date:  1970-07

2.  Variations in absorption and elimination rates of ethyl alcohol in a single subject.

Authors:  J G Wagner; J A Patel
Journal:  Res Commun Chem Pathol Pharmacol       Date:  1972-07

3.  Assay of warfarin: a rebuttal.

Authors:  J G Wagner
Journal:  J Pharm Sci       Date:  1971-08       Impact factor: 3.534

4.  In vivo and in vitro availability of commercial warfarin tablets.

Authors:  J G Wagner; P G Welling; K P Lee; J E Walker
Journal:  J Pharm Sci       Date:  1971-05       Impact factor: 3.534

5.  Genetic and environmental factors affecting ethanol metabolism in man.

Authors:  E S Vesell; J G Page; G T Passananti
Journal:  Clin Pharmacol Ther       Date:  1971 Mar-Apr       Impact factor: 6.875

6.  Absorption, excretion and half-life of clinimycin in normal adult males.

Authors:  J G Wagner; E Novak; N C Patel; C G Chidester; W L Lummis
Journal:  Am J Med Sci       Date:  1968-07       Impact factor: 2.378

7.  Absorption and elimination of ethosuximide in children.

Authors:  R A Buchanan; L Fernandez; A W Kinkel
Journal:  J Clin Pharmacol J New Drugs       Date:  1969 Nov-Dec

8.  Biological half-lives of the antibiotic lincomycin observed in repetitive experiments in the same subjects.

Authors:  J G Wagner; J I Northam; W T Sokolski
Journal:  Nature       Date:  1965-07-10       Impact factor: 49.962

9.  Urinary excretion of ephedrine in man without pH control following oral administration of three commercial ephedrine sulfate preparations.

Authors:  P G Welling; K P Lee; J A Patel; J E Walker; J G Wagner
Journal:  J Pharm Sci       Date:  1971-11       Impact factor: 3.534
  9 in total
  14 in total

1.  Within- and between-subject variations in pharmacokinetic parameters of ethanol by analysis of breath, venous blood and urine.

Authors:  A Norberg; J Gabrielsson; A W Jones; R G Hahn
Journal:  Br J Clin Pharmacol       Date:  2000-05       Impact factor: 4.335

2.  Stepwise determination of multicompartment disposition and absorption parameters from extravascular concentration-time data. Application to mesoridazine, flurbiprofen, flunarizine, labetalol, and diazepam.

Authors:  J G Wagner; D A Ganes; K K Midha; I Gonzalez-Younes; J C Sackellares; L D Olson; M B Affrime; J E Patrick
Journal:  J Pharmacokinet Biopharm       Date:  1991-08

3.  Pharmacokinetics of isoniazid and some metabolites in man.

Authors:  H G Boxenbaum; S Riegelman
Journal:  J Pharmacokinet Biopharm       Date:  1976-08

Review 4.  Individual differences in the disposition of drugs metabolised in the body.

Authors:  G Alvan
Journal:  Clin Pharmacokinet       Date:  1978 Mar-Apr       Impact factor: 6.447

5.  The kinetics of ethanol absorption and elimination in twins and supplementary repetitive experiments in singleton subjects.

Authors:  M Kopun; P Propping
Journal:  Eur J Clin Pharmacol       Date:  1977       Impact factor: 2.953

6.  Inter-individual and intra-individual variability of ethanol concentration-time profiles: comparison of ethanol ingestion before or after an evening meal.

Authors:  A G Fraser; S B Rosalki; G D Gamble; R E Pounder
Journal:  Br J Clin Pharmacol       Date:  1995-10       Impact factor: 4.335

7.  Pharmacokinetic and biopharmaceutic profile of chlordiazepoxide HC1 in healthy subjects: single-dose studies by the intravenous, intramuscular, and oral routes.

Authors:  H G Boxenbaum; K A Geitner; M L Jack; W R Dixon; H E Spiegel; J Symington; R Christian; J D Moore; L Weissman; S A Kaplan
Journal:  J Pharmacokinet Biopharm       Date:  1977-02

8.  Pharmacokinetic and biopharmaceutic profile of chlordiazepoxide HC1 in healthy subjects: multiple-dose oral administration.

Authors:  H G Boxenbaum; K A Geitner; M L Jack; W R Dixon; S A Kaplan
Journal:  J Pharmacokinet Biopharm       Date:  1977-02

Review 9.  Assessment of methods to identify sources of interindividual pharmacokinetic variations.

Authors:  E S Vesell; M B Penno
Journal:  Clin Pharmacokinet       Date:  1983 Sep-Oct       Impact factor: 6.447

10.  A twin study of ethanol metabolism.

Authors:  N G Martin; J Perl; J G Oakeshott; J B Gibson; G A Starmer; A V Wilks
Journal:  Behav Genet       Date:  1985-03       Impact factor: 2.805
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.